Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists Compounded Options Alongside New FDA-Approved…
PORTLAND, Ore., Dec. 26, 2025 /PRNewswire/ -- On or about October 27, 2025, CareOregon learned that one or more people looked…
PORTLAND, Ore., Dec. 26, 2025 /PRNewswire/ -- On or about October 27, 2025, Jackson Care Connect learned that one or…
PORTLAND, Ore., Dec. 26, 2025 /PRNewswire/ -- On or about October 27, 2025, Columbia Pacific CCO learned that one or more people…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…
Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed operating models, tightening third- and…
Platform Analysis: Injectable vs. Dissolving Tablet Formats, Prescription Requirements, Monthly Subscription Costs, and Timeline Expectations for Growth Hormone Secretagogue TherapyAUSTIN,…
Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026CANTON, Mass., Dec. 23,…
Centennial, Colorado--(Newsfile Corp. - December 24, 2025) - The Obesity Medicine Association (OMA) released its Position Statement on Medicare and…